Avoro Capital Advisors LLC Cerevel Therapeutics Holdings, Inc. Transaction History
Avoro Capital Advisors LLC
- $7.33 Billion
- Q2 2024
A detailed history of Avoro Capital Advisors LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 7,539,547 shares of CERE stock, worth $0. This represents 4.21% of its overall portfolio holdings.
Number of Shares
7,539,547
Previous 7,555,555
0.21%
Holding current value
$0
Previous $319 Million
3.47%
% of portfolio
4.21%
Previous 3.85%
Shares
3 transactions
Others Institutions Holding CERE
# of Institutions
242Shares Held
154MCall Options Held
2.19MPut Options Held
3.87M-
Bain Capital Investors LLC Boston, MA65.7MShares$065.37% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.15MShares$00.01% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Fil LTD Hamilton, D03.25MShares$00.14% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...